Abstract
Introduction
Enteric fever caused by Salmonella Typhi & Salmonella Paratyphi A.B.C . 1 Enteric fever due to infection with Salmonella enterica serovar Typhi or Salmonella enterica serovar Paratyphi A is estimated to cause more than 27 million infections each year worldwide with 216000 deaths. 2 After extensive outbreaks of typhiod fever occurred in Mexico and India in the early & mid 1970s, in which epidemic strains were resistant to chloramphenicol, the efficacy of this antimicrobial was in doubt. Alternative drugs for typhoid fever are ampicillin and trimethoprim. However, following outbreaks in the Indian subcontinent, the Arabian Gulf, the Philippines and South Africa in the late 1980s and early 1990s, in which causative strains were resistant to ampicillin and trimithoprim in addition to chloramphenicol, the efficacy of these antimicrobials has also been impaired. 3 In the last two decades, the worldwide emergence of multi-drug resistant strains of Salmonella has led to virtual withdrawal of chloramphenicol and its replacement with fluoroquinolones and third generation cephalosporins. Clinical treatment failures after the administration of ciprofloxacin and other fluoroquinolones to patient with typhoid fever attributable to these strains have been reported. The emergence of complete resistant to ciprofloxacin in S. Typhi or S. Paratyphi A would severely limit the choice of antimicrobial therapy for treating enteric fever. 4 Where fluoroquinolones, such as ciprofloxacin and ofloxacin, have become widely used, isolates of Salmonella enterica serovar Typhi and serovar Paratyphi A with reduced susceptibility to fluoroquinolones have become common. 2 The most common method of testing for resistance to ciprofloxacin in clinical laboratories is by disc diffusion, using discs with concentration of ciprofloxacin ranging from 1 to 5 mg/L. 5 However, isolates of Salmonella enterica serovars Typhi and Paratyphi A with reduced susceptibility to fluoroquinolones (as indicated in the laboratory by resistance to nalidixic acid) have now appeared in the Indian subcontinent, Vietnam and Tajikistan and treatment failures with fluoroquinolones have also been reported. Isolates of serovar Typhi in the United Kingdom had reduced susceptibility to ciprofloxacin. 6 In order to effectively monitor the changing trends in the level of antimicrobial for testing the susceptibility of Salmonella Typhi strains to selected antibiotics should be used routinely in large hospital settings in more geographical areas. 7 A national-guide line on the proper usage of antibiotics is required for urgent implementation in Bangladesh. 8 In the present study, sensitivity pattern of this four drugs including nalidixic acid was determined by disc diffusion method. Disc of the antimcrobial agents used in different strengths. Mueller-Hinton agar medium was used for disc diffusion test. A suspension of each isolate was made in sterile nutrient broth. At least three to five wellisolated colonies of the same morphological type was selected from an agar plate culture. The top of each colony was touched with a loop and the growth was transferred into a tube containing 4-5 ml of sterile nutrient broth. The turbidity of the actively growing broth culture was adjusted with that of the 0.5 McFarland standard, which is equivalent to 10 7 CFU/ml. The dried surface of a Mueller-Hinton agar plate was inoculated by streaking the swab over the entire sterile agar surface. The disc were placed over the inoculated surface about 15-20 mm away from the edge of the petridish and 24mm from center to center to prevent overlapping of zones of inhibition. In this method, a maximum of 5 discs were placed into a 90mm plate. After placing the antimicrobial disc, the inoculated plates were incubated at 37 0 C for 18-24 hours. Then the diameters of the zones of inhibition were measured in millimeter. The interpretive criteria to evaluate the susceptibility of the isolates were done according to Cultural Laboratory Standard Institute (CLSI) guideline.
Methods

This
Results
A total of 100 Salmonella strains were studied, of which 72 (72%) were Salmonella Typhi, 28 (28%) were S. Paratyphi A and none was S. Paratyphi B. Sensitivity pattern of ciprofloxacin, ofloxacin, ceftriaxone azithromycin and nalidixic acid among salmonella species by disc diffusion method was given in (Table-I ). 75 (75%) sensitive, 22 (22%) intermediately sensitive and 3 (3%) salmonella strains were resistant to ciprofloxacin. 100 (100%) strains were sensitive to ofloxacin. 94 (94%) strains were sensitive and 6 (6%) strains were intermediately sensitive to ceftriaxone. 71 (71%) strains were sensitive and 29 (29%) strains were intermediately sensitive to azithromycin. Again, 90 (90%) strains were resistant and 10 (10%) were sensitive to nalidixic acid. 
Discussion
In the present study, by disc diffusion method showed that only 3 % salomenlla isolates were resistant to ciprofloxacin, 22% were intermediate sensitive and 75% were sensitive to ciprofloxacin. The results were in consistent with the study of Gautam et al. (2004) 9 who showed that 79 % salmonella strains were sensitive to ciprofloxacin by disc diffusion method. A study by Chowta and Chowta (2005) 10 showed that there was in vitro sensitive to ciprofloxacin, but the patient did not respond to the drug therapy. These findings suggest that sensitivity of salmonella to ciprofloxacin in vivo gradually decreasing. A strain with decreased sensitive to ciprofloxacin was reported from the Indian subcontinent and south east and central Asia. Disc diffusion testing revealed that these isolates were resistant to nalidixic acid but sensitive to ciprofloxacin, according to the current CLSI interpretive criteria. 11 In the present study, 90% salmonella strains were resistant and 10% were sensitive to nalidixic acid by disc diffusion method. The resistant rate to nalidixic acid in this study was significantly higher than that of Chinh et al. (2000) 6 in Vietnam, who reported only 53% of isolates were resistant to nalidixic acid. Mendal (2004) 12 from Kolkata reported 100% salmonella strains were resistant to nalidixic acid, indicating the reduced susceptibility to ciprofloxacin. In present study, 73.33% of nalidixic acid resistant salmonella strains were sensitive, 23.33% were intermediate sensitive and 3.33% were resistant to ciprofloxacin. Among nalidixic acid sensitive salmonella strains, 80% strains were sensitive and 20% were resistant to ciprofloxacin. Therefore, nalidixic acid resistance determined by the disc diffusion method could be an indication of decreased susceptibility to ciprofloxacin. 13 The presence of nalildixic acid resistance has been suggested as a laboratory marker of isolates with reduced susceptibility to fluoroquinolones and indicates that invasive infection may fail to respond to fluoroquinolone therapy. 14 100% salmonella strains were sensitive to ofloxacin with zone diameter ³16 mm in this study. This finding correlates with Mandal et al. (2003) 12 , who found 99.04% salmonella strains were sensitive to ofloxacin by disc diffusion method with zone diameter ³16 mm. It also correlates with Choudhari and Bansal (1997) 15 and Kumar et al. (2001) 16 , who found to most of the strains 8 , who showed 88% S. Typhi were sensitive to ceftriaxone by disc diffusion method. Azithromycin in the present study showed that 29% of salmonella isolates were intermediate sensitive to azithromycin with zone diameter 14-17 mm with MIC 2-64 mg/ ml and 71% of isolates were sensitive to azithromycin by disc diffusion method had zone diamerter ³18 mm. In enteric fever, the role of azithromycin needs to be appreciated, as it is highly effective in removing intracellular salmonella, defervescence is rapid, gastrointestinal carriage is eradicated and it represents a potential alternative in pediatric populations where quinolones are contraindicated. 21 
Conclusion
This study has been revealed that most of the Salmonella typhi isolates which are resistant to nalidixic acid will also be resistant to ciprofloxacin. However, they may show in vitro susceptibility. For this reason, it is essential to find out a therapeutic alternative against this resistant organism.
